This invention relates to novel 4-(furo[3,2-c]pyridin-2-yl)-1,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-Met-mediated conditions, particularly cancer and other proliferative disorders.
本发明涉及一种新型4-(furo[3,2-c]pyridin-2-yl)-1,4-二氢
吡啶衍生物,具有
蛋白酪氨酸激酶抑制活性,制备方法和用于治疗c-Met介导的疾病或c-Met介导的病症,特别是癌症和其他增殖性疾病的用途。